Revised SPCs: Lynparza (olaparib) – all formulations
SPC updated to include angioedema and erythema nodsum as common and rare adverse events, respectively.
Source:
electronic Medicines compendium
SPC updated to include angioedema and erythema nodsum as common and rare adverse events, respectively.
electronic Medicines compendium